Waters, Genovis team up on automated CQA characterization

By The Science Advisory Board staff writers

April 13, 2021 -- Waters and Genovis are working together to develop and market routine biopharmaceutical characterization workflows of critical quality attributes (CQAs) of monoclonal antibodies (mAbs).

The goal is to develop automated workflows for the rapid and consistent characterization of CQAs of mAbs and other protein-based drugs in bioprocess development, formulation, stability testing, and quality control, according to the companies. The companies will combine Genovis' SmartEnzymes with automation, chromatography/time-of-flight mass spectrometry (MS), and application-specific software workflows from Waters, including its BioAccord liquid chromatography (LC)-MS system and Andrew+ pipefitting robot.

The workflows being developed will focus on three application areas: product variant analysis (e.g., glycosylation, oxidation), bioprocess stability monitoring, and biosimilar glycosylation analysis, the companies said.

Waters launches MAM workflow for protein-based drug analysis
Waters has introduced a new peptide multiattribute method (MAM) workflow for its BioAccord liquid chromatography-mass spectrometry system.
Waters launches new small molecule mass spectrometer
Waters has released its new time-of-flight mass spectrometer, the Acquity RDa Detector, for small molecule analysis.
Waters launches Acquity Premier LC solution
Waters has launched Acquity Premier, a next-generation liquid chromatography (LC) solution featuring MaxPeak high-performance surface technology.
Megadalton joins Waters' Immerse Cambridge labs
Megadalton Solutions has expanded its collaboration with Waters to bring its charge detection mass spectrometry technology to a broader set of biopharma...

Copyright © 2021 scienceboard.net

Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter